Bicycle therapeutics limited

NA

BCYC


Executive/
Director

Price

  • Last Close
  • $ 21.03
    $ -0.57 -2.64 %
    Dec 9, 2024
  • 52-Week High/Low
  • $26.1 - $13.29
  • YTD
  • 16.3%

  • Trading Volume
  • 10,637
  • Market Cap Full
  • $ 631.8M
  • Shares Outstanding
  • 30M
    May 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 65% -27.9% -28.1% 37.7%
Q2 - - - - -17.6% 4% 1.6% -61.8% 20% -2.1%
Q3 - - - - 10.5% 8% 37% 38.6% -21.3% -
Q4 - - - - -20.5% -4.6% 46.4% 27.3% -9.3% -
J F M A M J J A S O N D
2024 -3.5% 43.8% -0.8% -4.7% - - - - - - - -
2023 -6.7% -17.7% -6.4% -7.1% 21.4% 6.4% -3.6% -11.6% -7.6% -25.1% -4.3% 25.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%94%236%-51%-39%16%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - -0.73 -0.93 -1.30
Q2 - - - - 1.40 - -0.74 -0.9 -1.41
Q3 - - - - 0.53 - -0.59 -0.96 -1.26
Q4 - - - - - - -0.61 -1.01 -
A 0 0 0 0 -2.8 -2.7 -2.7 -3.8 -3.97

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 18 23.1 29.6 30
Jun - 18.1 24.1 29.6 30
Sep 17.9 19.3 25.5 29.7 -
Dec 17.9 21.3 29.4 29.7 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.5 2 2.5 3.5 1.4
Total Asset Turnover - - 0.1 0.1 0.1
Leverage
Debt Ratio 0.1 0.1 0.1 - -
Debt – Equity Ratio 0.1 0.1 0.2 - -
Interest Coverage 29.3 -66 52 -5.2 -
Equity multiplier 0.1 - - - -0.1